Login Register Cart 0
Current Alzheimer Research

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Translate in Chinese
Systematic Review Article

Multimodal Deep Learning Approaches for Early Detection of Alzheimer’s Disease: A Comprehensive Systematic Review of Image Processing Techniques

Author(s): Jabli Mohamed Amine*orcid of author and Moussa Mourad

Volume 22, Issue 8, 2025

Published on: 07 August, 2025

Page: [549 - 562] Pages: 14

DOI: 10.2174/0115672050401817250721190509

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction: Alzheimer's disease (AD) is the most common form of dementia, and it is important to diagnose the disease at an early stage to help people with the condition and their families. Recently, artificial intelligence, especially deep learning approaches applied to medical imaging, has shown potential in enhancing AD diagnosis. This comprehensive review investigates the current state of the art in multimodal deep learning for the early diagnosis of Alzheimer's disease using image processing.

Methods: The research underpinning this review spanned several months. Numerous deep learning architectures are examined, including CNNs, transfer learning methods, and combined models that use different imaging modalities, such as structural MRI, functional MRI, and amyloid PET. The latest work on explainable AI (XAI) is also reviewed to improve the understandability of the models and identify the particular regions of the brain related to AD pathology.

Results: The results indicate that multimodal approaches generally outperform single-modality methods, and three-dimensional (volumetric) data provides a better form of representation compared to two-dimensional images.

Discussion: Current challenges are also discussed, including insufficient and/or poorly prepared datasets, computational expense, and the lack of integration with clinical practice. The findings highlight the potential of applying deep learning approaches for early AD diagnosis and for directing future research pathways.

Conclusion: The integration of multimodal imaging with deep learning techniques presents an exciting direction for developing improved AD diagnostic tools. However, significant challenges remain in achieving accurate, reliable, and understandable clinical applications.

Keywords: Alzheimer’s disease, deep learning, convolutional neural networks, multimodal imaging, MRI, PET, early diagnosis.

Next »
[1]
Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers 2021; 7(1): 33.
[http://dx.doi.org/10.1038/s41572-021-00269-y] [PMID: 33986301]
[2]
2023 Alzheimer’s disease facts and figures. Alzheimers Dement 2023; 19(4): 1598-695.
[http://dx.doi.org/10.1002/alz.13016] [PMID: 36918389]
[3]
Behl T, Kaur I, Sehgal A, et al. The link between Alzheimer’s disease and stroke: A detrimental synergism. Ageing Res Rev 2024; 99: 102388.
[http://dx.doi.org/10.1016/j.arr.2024.102388] [PMID: 38914265]
[4]
Sinha S, Wal P, Goudanavar P, Divya S, Kimothi V, Jyothi D. Research on Alzheimer's disease (AD) involving the use of in vivo and in vitro models and mechanisms. CNS Agents Med Chem 2025; 25(2): 123-42.
[http://dx.doi.org/10.2174/0118715249293642240522054929] [PMID: 38803173]
[5]
Singh M, Agarwal V, Pancham P, et al. A comprehensive review and androgen deprivation therapy and its impact on alzheimer’s disease risk in older men with prostate cancer. Degener Neurol Neuromuscul Dis 2024; 14: 33-46.
[http://dx.doi.org/10.2147/DNND.S445130] [PMID: 38774717]
[6]
Qiu S, Joshi PS, Miller MI, et al. Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification. Brain 2020; 143(6): 1920-33.
[http://dx.doi.org/10.1093/brain/awaa137] [PMID: 32357201]
[7]
Spasov S, Passamonti L, Duggento A, Liò P, Toschi N. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer’s disease. Neuroimage 2019; 189: 276-87.
[http://dx.doi.org/10.1016/j.neuroimage.2019.01.031] [PMID: 30654174]
[8]
Cui R, Liu M. Hippocampus analysis by combination of 3-d densenet and shapes for alzheimer’s disease diagnosis. IEEE J Biomed Health Inform 2019; 23(5): 2099-107.
[http://dx.doi.org/10.1109/JBHI.2018.2882392] [PMID: 30475734]
[9]
Ebrahimighahnavieh MA, Luo S, Chiong R. Deep learning to detect Alzheimer’s disease from neuroimaging: A systematic literature review. Comput Methods Programs Biomed 2020; 187: 105242.
[http://dx.doi.org/10.1016/j.cmpb.2019.105242] [PMID: 31837630]
[10]
Wen J, Thibeau-Sutre E, Diaz-Melo M, et al. Convolutional neural networks for classification of Alzheimer’s disease: Overview and reproducible evaluation. Med Image Anal 2020; 63: 101694.
[http://dx.doi.org/10.1016/j.media.2020.101694] [PMID: 32417716]
[11]
Helaly HA, Badawy M, Hossny E. Deep learning approaches for Alzheimer’s disease detection from brain MRI: A comprehensive review. Neural Comput Appl 2024; 36(1): 1-25.
[http://dx.doi.org/10.1007/s00521-023-08697-5]
[12]
Ramzan F, Khan MUG, Rehmat A, et al. A deep learning approach for automated diagnosis and multi-class classification of Alzheimer’s disease stages using resting-state FMRI and residual neural networks. J Med Syst 2020; 44(2): 37.
[http://dx.doi.org/10.1007/s10916-019-1475-2] [PMID: 31853655]
[13]
Noor MBT, Zenia NZ, Kaiser MS, Mamun SA, Mahmud M. Application of deep learning in detecting neurological disorders from magnetic resonance images: A survey on the detection of Alzheimer’s disease, Parkinson’s disease and Schizophrenia. Brain Inform 2020; 7(1): 11.
[http://dx.doi.org/10.1186/s40708-020-00112-2] [PMID: 33034769]
[14]
Shen T, Jiang J, Lu J, et al. Predicting Alzheimer disease from mild cognitive impairment with a deep belief network based on 18F-FDG-PET images. Mol Imaging 2019; 18: 1536012119877285.
[http://dx.doi.org/10.1177/1536012119877285] [PMID: 31552787]
[15]
Feng C, Elazab A, Yang P, et al. Deep learning framework for Alzheimer’s disease diagnosis via 3D-CNN and FSBi-LSTM. IEEE Access 2019; 7: 63605-18.
[http://dx.doi.org/10.1109/ACCESS.2019.2913847]
[16]
Punjabi A, Martersteck A, Wang Y, Parrish TB, Katsaggelos AK. Neuroimaging modality fusion in Alzheimer’s classification using convolutional neural networks. PLoS One 2019; 14(12): 0225759.
[http://dx.doi.org/10.1371/journal.pone.0225759] [PMID: 31805160]
[17]
Ansart M, Epelbaum S, Bassignana G, et al. Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review. Med Image Anal 2021; 67: 101848.
[http://dx.doi.org/10.1016/j.media.2020.101848] [PMID: 33091740]
[18]
Abuhmed T, El-Sappagh S, Alonso JM. Robust hybrid deep learning models for Alzheimer’s progression detection. Knowl Base Syst 2021; 213: 106688.
[http://dx.doi.org/10.1016/j.knosys.2020.106688]
[19]
Rieke J, Eitel F, Weygandt M, Haynes JD, Ritter K. Visualizing convolutional networks for mri-based diagnosis of Alzheimer’s disease. Understanding and Interpreting Machine Learning in Medical Image Computing Applications. Cham: Springer 2018; pp. 24-31.
[http://dx.doi.org/10.1007/978-3-030-02628-8_3]
[20]
Böhle M, Eitel F, Weygandt M, Ritter K. Layer-wise relevance propagation for explaining deep neural network decisions in MRI-based Alzheimer’s disease classification. Front Aging Neurosci 2019; 11: 194.
[http://dx.doi.org/10.3389/fnagi.2019.00194] [PMID: 31417397]
[21]
Rudin C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat Mach Intell 2019; 1(5): 206-15.
[http://dx.doi.org/10.1038/s42256-019-0048-x] [PMID: 35603010]
[22]
Mamalakis A. Investigating the fidelity of explainable artificial intelligence methods for weather and climate applications. Artif Intell Earth Sys 2022; 1(4): 220012.
[http://dx.doi.org/10.1175/AIES-D-22-0012.1]
[23]
Yang W. Survey on explainable AI: From approaches, limitations, opportunities to metrics, recent advances and challenges. CAAI Artif Intell Res 2023; 2: 19.
[http://dx.doi.org/10.1007/s44230-023-00038-y]
[24]
Kindermans PJ. The (un)reliability of saliency methods. Explainable AI: Interpreting, Explaining and Visualizing Deep Learning. Cham: Springer 2019; pp. 267-80.
[http://dx.doi.org/10.1007/978-3-030-28954-6_10]
[25]
Jacovi A. Formalizing trust in artificial intelligence: Prerequisites, causes and goals of human trust in AI. Proceedings of the 2021 ACM Conference on Fairness, Accountability, and Transparency (FAccT ’21). 2021, pp. 624-635.
[http://dx.doi.org/10.1145/3442188.3445923]
[26]
Poursabzi-Sangdeh F. Manipulating and Measuring Model Interpretability. Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems (CHI ’21). 2021, pp. (1-52).
[http://dx.doi.org/10.1145/3411764.3445315]
[27]
Hoffmann F. Bridging the Gap in XAI—the need for reliable metrics and robust evaluation strategies. arXiv:250204695 2025; 1-5.
[28]
Velmurugan M. Developing guidelines for functionally-grounded evaluation of explainable AI. Knowl Base Syst 2025; 299: 112069.
[http://dx.doi.org/10.1016/j.knosys.2024.112069]
[29]
Khvostikov A, Aderghal K, Benois-Pineau J, Krylov A. 3D CNN-based classification using sMRI and MD-DTI images for Alzheimer’s disease studies. arXiv:180105968 2018; 1-7.
[http://dx.doi.org/10.48550/arXiv.1801.05968]
[30]
Payan A, Montana G. Predicting Alzheimer’s disease: A neuroimaging study with 3D convolutional neural networks. IEEE International Conference on Image Processing. 2015, pp. 1-5.
[http://dx.doi.org/10.1109/ICIP.2015.7351000]
[31]
Hosseini-Asl E, Keynton R, El-Baz A. Alzheimer’s disease diagnostics by adaptation of 3D convolutional network. IEEE International Conference on Image Processing. 2016, pp. 126-130.
[http://dx.doi.org/10.1109/ICIP.2016.7532332]
[32]
Chen AA, Luo C, Chen Y, Shinohara RT, Shou H. Privacy-preserving harmonization via distributed ComBat. Neuroimage 2022; 248: 118822.
[http://dx.doi.org/10.1016/j.neuroimage.2021.118822] [PMID: 34958950]
[33]
Zhou X, Qiu S, Joshi PS, et al. Enhancing magnetic resonance imaging-driven Alzheimer’s disease classification performance using generative adversarial learning. Alzheimers Res Ther 2021; 13(1): 60.
[http://dx.doi.org/10.1186/s13195-021-00797-5] [PMID: 33766132]
[34]
Mitrovska A, Safari P, Ritter K, Shariati B, Fischer JK. Secure federated learning for Alzheimer’s disease detection. Front Aging Neurosci 2024; 16: 1324032.
[http://dx.doi.org/10.3389/fnagi.2024.1324032] [PMID: 38515517]
[35]
Marinescu RV, Oxtoby NP, Young AL. Tadpole challenge: Prediction of longitudinal evolution in alzheimer’s disease. arXiv2018:180503909 2018; 1-6.
[36]
Ji Y, Zhu L, Yang Z. Improved Alzheimer’s disease diagnosis using ensemble learning with convolutional neural networks and structural MRI. Front Aging Neurosci 2023; 15: 1173265.
[http://dx.doi.org/10.3389/fnagi.2023.1173265]
[37]
Prajapati C, Rai SN, Singh AK, et al. An update of fungal endophyte diversity and strategies for augmenting therapeutic potential of their potent metabolites: Recent advancement. Appl Biochem Biotechnol 2025; 197(5): 2799-866.
[http://dx.doi.org/10.1007/s12010-024-05098-9] [PMID: 39907846]
[38]
Kang SK, Seo S, Shin SA. Deep learning for Alzheimer’s disease: A systematic review of structural and functional brain imaging. Diagnostics 2022; 12(5): 1075.
[http://dx.doi.org/10.3390/diagnostics12051075] [PMID: 35626231]
[39]
Samper-González J, Burgos N, Bottani S, et al. Reproducible evaluation of classification methods in Alzheimer’s disease: Framework and application to MRI and PET data. Neuroimage 2018; 183: 504-21.
[http://dx.doi.org/10.1016/j.neuroimage.2018.08.042] [PMID: 30130647]
[40]
Farooq A, Anwar S, Awais M, Rehman S. A deep CNN based multi-class classification of Alzheimer’s disease using MRI. IEEE International Conference on Imaging Systems and Techniques. 2017, pp. 1-6.
[http://dx.doi.org/10.1109/IST.2017.8261460]
[41]
Zhang D, Wang Y, Zhou L, Yuan H, Shen D. Multimodal classification of Alzheimer’s disease and mild cognitive impairment. Neuroimage 2011; 55(3): 856-67.
[http://dx.doi.org/10.1016/j.neuroimage.2011.01.008] [PMID: 21236349]
[42]
Abd El-Latif AA, Chelloug SA, Alabdulhafith M, Hammad M. Accurate detection of alzheimer’s disease using lightweight deep learning model on MRI data. Diagnostics 2023; 13(7): 1216.
[43]
Zhou T, Thung KH, Zhu X, Shen D. Effective feature learning and fusion of multimodality data using stage‐wise deep neural network for dementia diagnosis. Hum Brain Mapp 2019; 40(3): 1001-16.
[http://dx.doi.org/10.1002/hbm.24428] [PMID: 30381863]
[44]
Liu S, Yadav C, Fernandez-Granda C, Razavian N. On the design of convolutional neural networks for automatic detection of Alzheimer’s disease. Machine Learn Medi Imag 2020; 11861: 287-96.
[http://dx.doi.org/10.1007/978-3-030-32692-0_3]
[45]
Yadav A, Singh N, Singh A, et al. Investigation of serum pro-inflammatory markers and trace elements among short stature in eastern uttar pradesh and bihar populations. J Inflamm Res 2024; 17: 6063-73.
[http://dx.doi.org/10.2147/JIR.S473895] [PMID: 39253565]
[46]
Tripathi P, Lodhi A, Rai S, et al. Review of pharmacotherapeutic targets in Alzheimer’s disease and its management using traditional medicinal plants. Degener Neurol Neuromuscul Dis 2024; 14: 47-74.
[http://dx.doi.org/10.2147/DNND.S452009] [PMID: 38784601]
[47]
Altay O, Ulas C, Kara E, Guler E, Altay EE. Attention-based recurrent neural networks for Alzheimer’s disease detection using structural MRI. Comput Biol Med 2023; 158: 106887.
[http://dx.doi.org/10.1016/j.compbiomed.2023.106887]
[48]
Ramakrishna K, Nalla LV, Naresh D, et al. WNT-β catenin signaling as a potential therapeutic target for neurodegenerative diseases: Current status and future perspective. Diseases 2023; 11(3): 89.
[http://dx.doi.org/10.3390/diseases11030089] [PMID: 37489441]
[49]
Tripathi PN, Srivastava P, Sharma P, et al. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem 2019; 85: 82-96.
[http://dx.doi.org/10.1016/j.bioorg.2018.12.017] [PMID: 30605887]
[50]
Srivastava P, Tripathi PN, Sharma P, et al. Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory. Eur J Med Chem 2019; 163: 116-35.
[http://dx.doi.org/10.1016/j.ejmech.2018.11.049] [PMID: 30503937]
[51]
Venugopalan J, Tong L, Hassanzadeh HR, Wang MD. Multimodal deep learning models for early detection of Alzheimer’s disease stage. Sci Rep 2021; 11(1): 3254.
[http://dx.doi.org/10.1038/s41598-020-74399-w] [PMID: 33547343]
[52]
Castellano G, Esposito A, Lella E, Montanaro G, Vessio G. Automated detection of Alzheimer’s disease: A multi-modal approach with 3D MRI and amyloid PET. Sci Rep 2024; 14(1): 5210.
[http://dx.doi.org/10.1038/s41598-024-56001-9] [PMID: 38433282]
[53]
Chamakuri R, Janapana H. A systematic review on recent methods on deep learning for automatic detection of Alzheimer’s disease. Med Novel Technol Devices 2025; 25: 100343.
[http://dx.doi.org/10.1016/j.medntd.2024.100343]
[54]
Grande G, Valletta M, Rizzuto D, et al. . Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community. Nat Med 2025; 31: 2027-35.
[http://dx.doi.org/10.1038/s41591-025-03605-x]
[55]
Sarraf S, Tofighi G. Classification of Alzheimer’s disease using fMRI data and deep learning convolutional neural networks. arXiv:160308631 2016; 1-6.
[http://dx.doi.org/10.48550/arXiv.1603.08631]
[56]
Rai SN, Singh C, Singh A, Singh MP, Singh BK. Mitochondrial dysfunction: A potential therapeutic target to treat Alzheimer’s disease. Mol Neurobiol 2020; 57(7): 3075-88.
[http://dx.doi.org/10.1007/s12035-020-01945-y] [PMID: 32462551]
[57]
Li F, Tran L, Thung KH, Ji S, Shen D, Li J. A robust deep model for improved classification of AD/MCI patients. IEEE J Biomed Health Inform 2019; 23(4): 1613-23.
[http://dx.doi.org/10.1109/JBHI.2018.2879501] [PMID: 25955998]
[58]
Basaia S, Agosta F, Wagner L, et al. Automated classification of Alzheimer’s disease and mild cognitive impairment using a single MRI and deep neural networks. Neuroimage Clin 2019; 21: 101645.
[http://dx.doi.org/10.1016/j.nicl.2018.101645] [PMID: 30584016]
[59]
Suk HI, Lee SW, Shen D. Deep sparse multi-task learning for feature selection in Alzheimer’s disease diagnosis. Brain Struct Funct 2017; 222(7): 3249-64.
[http://dx.doi.org/10.1007/s00429-017-1459-2] [PMID: 25993900]
[60]
Cui R, Liu M. RNN-based longitudinal analysis for diagnosis of Alzheimer’s disease. Comput Med Imaging Graph 2019; 73: 1-10.
[http://dx.doi.org/10.1016/j.compmedimag.2019.01.005] [PMID: 30763637]
[61]
Jung J. Essential properties and explanation effectiveness of explainable artificial intelligence in healthcare: A systematic review. Heliyon 2023; 9(5): e16110.
[http://dx.doi.org/10.1016/j.heliyon.2023.e16110]
[62]
Rathore S, Habes M, Iftikhar MA, Shacklett A, Davatzikos C. A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer’s disease and its prodromal stages. Neuroimage 2017; 155: 530-48.
[http://dx.doi.org/10.1016/j.neuroimage.2017.03.057] [PMID: 28414186]

Rights & Permissions Print Cite
Article Metrics
Pdf icon 40
Html icon 2
Find your institution